» Articles » PMID: 39920572

Neuroborreliosis with Encephalitis: a Broad Spectrum of Clinical Manifestations

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2025 Feb 7
PMID 39920572
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lyme neuroborreliosis is the disseminated stage of an infectious disease caused by Borrelia burgdorferi (BB). The most prevalent clinical manifestations include meningoradiculitis and involvement of the cranial nerves with lymphocytic meningitis. Facial nerve is the most frequently affected cranial nerve. Neuroborreliosis presenting as encephalitis is only scarcely described in the literature.

Methods: Medical records of patients between 2014 and 2024 were screened and reviewed for neuroborreliosis. Patients were only included if they met the diagnostic criteria for definite neuroborreliosis.

Results: A total of seven patients with neuroborreliosis induced encephalitis were identified. The median age was 72 years, and except for one man, all patients were women. Clinical manifestations ranged from cognitive impairments resembling primary dementia to movement disorders mimicking Parkinson's disease, tremor, and epileptic seizures. In 5/7 patients (71%) they occurred between August to September. In addition to central nervous system involvement, all patients exhibited characteristic features of neuroborreliosis like painful meningoradiculitis or peripheral facial palsy. An elevated cell count in cerebrospinal fluid (CSF), positive oligoclonal bands, and blood-CSF barrier dysfunction indicated by an elevated albumin quotient (QAlb) was found in all patients. Advanced age, in which immunosenescence can occur, might contribute in developing encephalitis caused by neuroborreliosis in the patients of this cohort.

Conclusion: Neuroborreliosis can present with symptoms that mimic various neurological disorders, such as dementia, movement disorders, and epilepsy. Radiculitis, peripheral facial palsy or meningitis are an additional hint for this infectious disease. Analysis of CSF, which includes testing for intrathecally produced BB antibodies, is crucial for the diagnosis.

References
1.
Oschmann P, DORNDORF W, Hornig C, Schafer C, WELLENSIEK H, Pflughaupt K . Stages and syndromes of neuroborreliosis. J Neurol. 1998; 245(5):262-72. DOI: 10.1007/s004150050216. View

2.
Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz H, Hunfeld K . Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. Ger Med Sci. 2020; 18:Doc03. PMC: 7174852. DOI: 10.3205/000279. View

3.
Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I . EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2009; 17(1):8-16, e1-4. DOI: 10.1111/j.1468-1331.2009.02862.x. View

4.
Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B . Clinical manifestations and diagnosis of neuroborreliosis. Ann N Y Acad Sci. 1988; 539:46-55. DOI: 10.1111/j.1749-6632.1988.tb31837.x. View

5.
Kaiser R, Lucking C . Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci. 1993; 118(1):64-72. DOI: 10.1016/0022-510x(93)90247-v. View